查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968220

基於半導體的個人化醫療解決方案市場分析及預測（至2035年）：按類型、產品、服務、技術、組件、應用、最終用戶、設備、製程和解決方案分類

Semiconductor-Based Personalized Medicine Solutions Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Device, Process, Solutions
出版日期: | 出版商: Global Insight Services | 英文 386 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

以半導體為基礎的個人化醫療解決方案市場預計將從2024年的5.579億美元成長到2034年的13.988億美元，複合年成長率約為9.6%。該市場涵蓋利用半導體裝置為個別患者量身定做治療方案的技術。這些解決方案整合了生物感測器、微陣列和實驗室晶片技術，並分析基因數據以提高診斷準確性和治療效果。基因組學的進步和對精準醫療日益成長的關注是推動該市場成長的主要因素，加速了數據處理和小型化領域的創新。

半導體個人化醫療解決方案市場正經歷強勁成長，這主要得益於精準診斷和個人化治療性介入的進步。其中，診斷領域的成長速度最快，基因測序和分子診斷引領著這一成長趨勢。這些技術在提供精準且個人化的健康資訊方面表現出色。次世代定序（NGS）技術在該領域至關重要，能夠實現全面的基因分析。

市場區隔
類型 診斷設備、治療設備、監測設備、基因組解決方案、蛋白質體學解決方案、代謝體學解決方案
產品 晶片、微陣列、生物感測器、實驗室晶片、定序平台、照護現場設備、穿戴式設備
服務 諮詢服務、整合服務、維修服務、數據分析、基因檢測服務
科技 奈米技術、微流體、生物資訊學、人工智慧、機器學習、雲端運算
成分 感測器、換能器、微處理器、記憶體、致動器、電源單元
目的 腫瘤科、心臟科、神經科、感染疾病、內分泌科、罕見疾病科
最終用戶 醫院、研究機構、製藥公司、學術機構、診斷中心
裝置 手持設備、行動裝置、桌上型設備、穿戴式設備
過程 檢體製備、數據收集、數據分析和結果解釋。
解決方案 整合系統、獨立系統、客製化解決方案、承包解決方案

治療設備的成長速度位居第二，這主要得益於半導體技術在藥物研發和藥物傳輸系統的應用。微機電系統（MEMS）支援的標靶藥物輸送機制備受關注，並有助於提高治療效果。個人化醫療設備，尤其是穿戴式健康監測設備，透過提供即時健康數據和個人化健康管理，也推動了市場成長。

此外，人工智慧（AI）與半導體技術的融合正在拓展市場潛力，透過先進的數據分析，實現個人化治療方案的發展。隨著產業的不斷發展，科技公司與醫療服務提供者之間的合作日益重要，這將推動創新並擴大市場機會。

基於半導體的個人化醫療解決方案市場正經歷動態變化，市場佔有率、定價策略和創新產品推出等格局都在不斷演變。市場領導正在策略性地調整定價模式，以提高可及性並保持盈利。尖端產品的推出正在推動市場競爭和消費者需求。在醫療基礎設施和技術生態系統完善的地區，這一趨勢尤其顯著。各公司正利用半導體技術的進步來提供個人化醫療解決方案，並以此建立競爭優勢。

在競爭標竿領域，主要企業不斷創新以超越競爭對手。法規結構，尤其是在北美和歐洲，對塑造市場動態、保障安全和促進創新至關重要。競爭格局的特點是策略聯盟和收購，旨在擴大市場影響和技術能力。隨著法規環境的演變，挑戰和機會並存，影響打入市場策略和合規成本。這些因素的相互作用凸顯了市場的複雜性和成長潛力。

主要趨勢和促進因素：

半導體個人化醫療解決方案市場正經歷顯著成長，這主要得益於技術進步和對個人化醫療解決方案日益成長的需求。關鍵趨勢包括人工智慧 (AI) 和機器學習在診斷領域的應用，從而提高診斷的準確性和效率。穿戴式醫療設備的普及也是一大趨勢，能夠實現即時健康監測和數據收集。推動該市場成長的因素之一是需要個人化治療方案的慢性病盛行率不斷上升。對預防性醫療保健的日益重視進一步加速了對能夠實現早期檢測和早期療育的半導體解決方案的需求。此外，遠端醫療和遠端患者監護系統的擴展也加速了半導體技術在醫療保健領域的應用。新興市場醫療基礎設施的快速發展蘊藏著許多機會。那些致力於開發經濟高效且擴充性的半導體解決方案的公司將佔有利地位，最大限度地掌握這些機會。此外，科技公司與醫療服務提供者之間的合作正在推動整合解決方案的開發，從而改善患者預後並促進市場成長。

美國關稅的影響：

全球基於半導體的個人化醫療解決方案市場日益受到關稅、地緣政治風險和不斷變化的供應鏈趨勢的影響。嚴重依賴半導體進口的日本和韓國正在加強國內產能以減輕關稅的影響。同時，中國正加速發展國內半導體產業以應對出口限制，而台灣雖然易受中美緊張局勢的影響，但仍保持其在晶片製造領域的重要作用。母市場正呈現強勁成長勢頭，主要得益於精準醫療和數位健康技術的進步。預計到2035年，在供應鏈保持韌​​性且區域間策略合作到位的情況下，該市場將進一步擴張。此外，中東衝突持續推高全球能源價格，間接影響半導體生產成本和交貨時間，並塑造市場趨勢。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 診斷設備
    • 治療設備
    • 監控設備
    • 基因組解決方案
    • 蛋白質體學解決方案
    • 代謝體學解決方案
  • 市場規模及預測：依產品分類
    • 提示
    • 微陣列
    • 生物感測器
    • 實驗室晶片
    • 定序平台
    • 照護現場設備
    • 穿戴式裝置
  • 市場規模及預測：依服務分類
    • 諮詢
    • 綜合服務
    • 維護服務
    • 數據分析
    • 基因檢測服務
  • 市場規模及預測：依技術分類
    • 奈米科技
    • 微流體技術
    • 生物資訊學
    • 人工智慧
    • 機器學習
    • 雲端運算
  • 市場規模及預測：依組件分類
    • 感應器
    • 感應器
    • 微處理器
    • 儲存裝置
    • 致動器
    • 電源單元
  • 市場規模及預測：依應用領域分類
    • 腫瘤學
    • 心臟病學
    • 神經病學
    • 感染疾病
    • 內分泌學
    • 罕見疾病
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 研究所
    • 製藥公司
    • 學術機構
    • 診斷中心
  • 市場規模及預測：依設備分類
    • 手持裝置
    • 行動裝置
    • 桌上型裝置
    • 穿戴式裝置
  • 市場規模及預測：依製程分類
    • 檢體預處理
    • 數據收集
    • 數據分析
    • 結果解讀
  • 市場規模及預測：依解決方案分類
    • 整合系統
    • 獨立系統
    • 客製化解決方案
    • 承包解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Bio-Rad Laboratories
  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Qiagen
  • Perkin Elmer
  • Roche Diagnostics
  • Bruker Corporation
  • Myriad Genetics
  • Adaptive Biotechnologies
  • Guardant Health
  • Exact Sciences
  • Natera
  • Foundation Medicine
  • Tempus Labs
  • Fulgent Genetics
  • Color Genomics
  • Personalis
  • Twist Bioscience
  • 10x Genomics

第9章 關於我們

簡介目錄
Product Code: GIS32680

Semiconductor-Based Personalized Medicine Solutions Market is anticipated to expand from $557.9 million in 2024 to $1,398.8 million by 2034, growing at a CAGR of approximately 9.6%. The Semiconductor-Based Personalized Medicine Solutions Market encompasses technologies that leverage semiconductor devices to tailor medical treatments to individual patients. These solutions integrate biosensors, microarrays, and lab-on-chip technologies to analyze genetic data, enhancing diagnostic precision and therapeutic efficacy. The market is driven by advancements in genomics and a growing emphasis on precision healthcare, fostering innovations in data processing and miniaturization.

The Semiconductor-Based Personalized Medicine Solutions Market is experiencing robust growth, propelled by advancements in precision diagnostics and tailored therapeutic interventions. The diagnostics segment is the top performer, with genomic sequencing and molecular diagnostics leading, driven by their ability to offer precise, individualized health insights. Within this segment, next-generation sequencing (NGS) technologies are pivotal, enabling comprehensive genetic profiling.

Market Segmentation
TypeDiagnostic Devices, Therapeutic Devices, Monitoring Devices, Genomic Solutions, Proteomic Solutions, Metabolomic Solutions
ProductChips, Microarrays, Biosensors, Lab-on-a-chip, Sequencing Platforms, Point-of-Care Devices, Wearable Devices
ServicesConsulting, Integration Services, Maintenance Services, Data Analytics, Genetic Testing Services
TechnologyNanotechnology, Microfluidics, Bioinformatics, Artificial Intelligence, Machine Learning, Cloud Computing
ComponentSensors, Transducers, Microprocessors, Memory Devices, Actuators, Power Supply Units
ApplicationOncology, Cardiology, Neurology, Infectious Diseases, Endocrinology, Rare Diseases
End UserHospitals, Research Laboratories, Pharmaceutical Companies, Academic Institutions, Diagnostic Centers
DeviceHandheld Devices, Portable Devices, Benchtop Devices, Wearable Devices
ProcessSample Preparation, Data Collection, Data Analysis, Result Interpretation
SolutionsIntegrated Systems, Standalone Systems, Custom Solutions, Turnkey Solutions

The therapeutics segment ranks as the second highest performer, fueled by the integration of semiconductor technologies in drug development and delivery systems. Targeted drug delivery mechanisms, supported by microelectromechanical systems (MEMS), are gaining prominence, enhancing treatment efficacy. Personalized medical devices, particularly wearable health monitors, are also contributing to market growth, offering real-time health data and personalized health management.

The convergence of AI with semiconductor technologies is further augmenting market potential, providing sophisticated data analytics for personalized treatment plans. As the industry evolves, collaborations between tech companies and healthcare providers are becoming increasingly vital, driving innovation and expanding market opportunities.

The semiconductor-based personalized medicine solutions market is witnessing a dynamic shift marked by an evolving landscape of market share, pricing strategies, and innovative product launches. Market leaders are strategically aligning their pricing models to enhance accessibility while maintaining profitability. The introduction of cutting-edge products is catalyzing competition and driving consumer demand. This trend is particularly evident in regions with robust healthcare infrastructures and technological ecosystems. Companies are leveraging advancements in semiconductor technology to deliver personalized medical solutions, thereby fostering a competitive edge.

In the realm of competition benchmarking, key players are continuously innovating to outpace rivals. Regulatory frameworks, particularly in North America and Europe, are pivotal in shaping market dynamics, ensuring safety, and fostering innovation. The competitive landscape is characterized by strategic partnerships and acquisitions aimed at expanding market presence and technological capabilities. As regulatory environments evolve, they present both challenges and opportunities, influencing market entry strategies and compliance costs. The interplay of these factors underscores the market's complexity and potential for growth.

Geographical Overview:

The semiconductor-based personalized medicine solutions market is witnessing diverse growth across global regions. North America leads with robust R&D investments and a strong healthcare infrastructure. The region's focus on precision medicine and technological advancements drives market expansion. Europe follows, supported by government initiatives and collaborations between tech firms and healthcare providers. The emphasis on personalized healthcare solutions enhances the market's trajectory. In Asia Pacific, rapid technological adoption and a growing patient population fuel demand. Countries like China and India are emerging as key growth pockets, driven by increased healthcare spending and innovation. Latin America shows promise, with Brazil and Mexico investing in healthcare modernization and semiconductor technologies. Meanwhile, the Middle East & Africa are recognizing the potential of personalized medicine, with countries like the UAE and South Africa making strides in healthcare infrastructure. These regions present lucrative opportunities for market players seeking expansion.

Key Trends and Drivers:

The semiconductor-based personalized medicine solutions market is experiencing remarkable growth, driven by technological advancements and increasing demand for tailored healthcare solutions. Key trends include the integration of artificial intelligence and machine learning in diagnostics, which enhances precision and efficiency. The proliferation of wearable medical devices is another significant trend, offering real-time health monitoring and data collection. Drivers of this market include the rising prevalence of chronic diseases, which necessitates personalized treatment approaches. The growing emphasis on preventive healthcare further fuels demand for semiconductor-based solutions, enabling early detection and intervention. Additionally, the expansion of telemedicine and remote patient monitoring systems is accelerating the adoption of semiconductor technologies in healthcare. Opportunities abound in emerging markets where healthcare infrastructure is evolving rapidly. Companies that innovate in cost-effective and scalable semiconductor solutions are well-positioned to capitalize on these opportunities. Furthermore, collaborations between tech firms and healthcare providers are fostering the development of integrated solutions, enhancing patient outcomes and driving market growth.

US Tariff Impact:

The global semiconductor-based personalized medicine solutions market is increasingly influenced by tariffs, geopolitical risks, and evolving supply chain dynamics. Japan and South Korea, heavily reliant on semiconductor imports, are enhancing domestic capabilities to mitigate tariff impacts. Concurrently, China is accelerating its indigenous semiconductor development in response to export restrictions, while Taiwan remains a pivotal player in chip fabrication, albeit vulnerable to US-China tensions. The parent market is witnessing robust growth, driven by advancements in precision medicine and digital health technologies. By 2035, the market is expected to flourish, contingent upon resilient supply chains and strategic regional collaborations. Additionally, Middle East conflicts continue to exert pressure on global energy prices, indirectly affecting semiconductor production costs and timelines, thereby shaping market trajectories.

Key Players:

Bio- Rad Laboratories, Illumina, Thermo Fisher Scientific, Agilent Technologies, Qiagen, Perkin Elmer, Roche Diagnostics, Bruker Corporation, Myriad Genetics, Adaptive Biotechnologies, Guardant Health, Exact Sciences, Natera, Foundation Medicine, Tempus Labs, Fulgent Genetics, Color Genomics, Personalis, Twist Bioscience, 10x Genomics

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Device
  • 2.9 Key Market Highlights by Process
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Diagnostic Devices
    • 4.1.2 Therapeutic Devices
    • 4.1.3 Monitoring Devices
    • 4.1.4 Genomic Solutions
    • 4.1.5 Proteomic Solutions
    • 4.1.6 Metabolomic Solutions
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Chips
    • 4.2.2 Microarrays
    • 4.2.3 Biosensors
    • 4.2.4 Lab-on-a-chip
    • 4.2.5 Sequencing Platforms
    • 4.2.6 Point-of-Care Devices
    • 4.2.7 Wearable Devices
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Integration Services
    • 4.3.3 Maintenance Services
    • 4.3.4 Data Analytics
    • 4.3.5 Genetic Testing Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Nanotechnology
    • 4.4.2 Microfluidics
    • 4.4.3 Bioinformatics
    • 4.4.4 Artificial Intelligence
    • 4.4.5 Machine Learning
    • 4.4.6 Cloud Computing
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Sensors
    • 4.5.2 Transducers
    • 4.5.3 Microprocessors
    • 4.5.4 Memory Devices
    • 4.5.5 Actuators
    • 4.5.6 Power Supply Units
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Oncology
    • 4.6.2 Cardiology
    • 4.6.3 Neurology
    • 4.6.4 Infectious Diseases
    • 4.6.5 Endocrinology
    • 4.6.6 Rare Diseases
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Research Laboratories
    • 4.7.3 Pharmaceutical Companies
    • 4.7.4 Academic Institutions
    • 4.7.5 Diagnostic Centers
  • 4.8 Market Size & Forecast by Device (2020-2035)
    • 4.8.1 Handheld Devices
    • 4.8.2 Portable Devices
    • 4.8.3 Benchtop Devices
    • 4.8.4 Wearable Devices
  • 4.9 Market Size & Forecast by Process (2020-2035)
    • 4.9.1 Sample Preparation
    • 4.9.2 Data Collection
    • 4.9.3 Data Analysis
    • 4.9.4 Result Interpretation
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Integrated Systems
    • 4.10.2 Standalone Systems
    • 4.10.3 Custom Solutions
    • 4.10.4 Turnkey Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Device
      • 5.2.1.9 Process
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Device
      • 5.2.2.9 Process
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Device
      • 5.2.3.9 Process
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Device
      • 5.3.1.9 Process
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Device
      • 5.3.2.9 Process
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Device
      • 5.3.3.9 Process
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Device
      • 5.4.1.9 Process
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Device
      • 5.4.2.9 Process
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Device
      • 5.4.3.9 Process
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Device
      • 5.4.4.9 Process
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Device
      • 5.4.5.9 Process
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Device
      • 5.4.6.9 Process
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Device
      • 5.4.7.9 Process
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Device
      • 5.5.1.9 Process
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Device
      • 5.5.2.9 Process
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Device
      • 5.5.3.9 Process
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Device
      • 5.5.4.9 Process
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Device
      • 5.5.5.9 Process
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Device
      • 5.5.6.9 Process
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Device
      • 5.6.1.9 Process
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Device
      • 5.6.2.9 Process
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Device
      • 5.6.3.9 Process
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Device
      • 5.6.4.9 Process
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Device
      • 5.6.5.9 Process
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Bio- Rad Laboratories
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Illumina
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Thermo Fisher Scientific
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Agilent Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Qiagen
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Perkin Elmer
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Roche Diagnostics
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Bruker Corporation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Myriad Genetics
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Adaptive Biotechnologies
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Guardant Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Exact Sciences
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Natera
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Foundation Medicine
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Tempus Labs
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Fulgent Genetics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Color Genomics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Personalis
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Twist Bioscience
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 10x Genomics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us